Meng-Chuan Lai is associate professor of psychiatry at the University of Toronto in Canada.
Meng-Chuan Lai
Assistant professor
University of Toronto
From this contributor
Quashing sex bias in autism research calls for participant rainbow
Autism researchers must attend to the need for sex and gender diversity in study design as a rule rather than as an exception.
Quashing sex bias in autism research calls for participant rainbow
By
Meng-Chuan Lai
25 September 2018 | 6 min read
Brains of girls, boys may mark distinct paths to autism
Differences between the brains of men and women with autism may help explain why men are more susceptible to the condition and women appear to be protected from it.
Brains of girls, boys may mark distinct paths to autism
By
Meng-Chuan Lai
19 October 2015 | 7 min read
Mind the gender gap
Autism may be male-biased in prevalence, but our understanding of it should not be, argues Meng-Chuan Lai.
Explore more from The Transmitter
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
Supported by a $40 million NIH grant, Yale brain shuttle technology raises questions
Yale University claims its STEP platform might be able to deliver gene-editing tools into the brain via multiple routes. Researchers are eager to see more.
By
Natalia Mesa
3 June 2026 | 11 min read
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
What counts as a ‘naturalistic’ behavior?
Nedah Nemati explains how neuroscience methods and the lived experience of the scientists themselves shape how we define the behaviors we seek to explain.
By
Paul Middlebrooks
3 June 2026 | 1 min read
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
Allen Institute sets sights on treatments for five brain diseases
The Brain Health Accelerator program aims to harness single-cell transcriptomics and cell-type-specific genetic tools to develop treatments for Alzheimer’s, Huntington’s and Parkinson’s diseases, Lewy body dementia and ALS.
By
Calli McMurray
2 June 2026 | 5 min read